Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels

Acta Obstetricia et Gynecologica Scandinavica

Volumn 82, Issue 9, 2003, Pages 797-802

  Madazli, Riza ^a,b   Aydin, Seval ^a   Uludag, Seyfettin ^a   Vildan, Ocak ^a   Tolun, Necati ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Cytokines; Fibronectin; Preeclampsia

Indexed keywords

CYTOKINE; FIBRONECTIN; GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; PLACENTAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE RELEASE; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; CYTOKINES; DIASTOLE; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBRONECTINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-6; INTERLEUKIN-8; LYMPHOKINES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; RECEPTORS, INTERLEUKIN-2; RECEPTORS, TUMOR NECROSIS FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0042333449     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2003.00206.x     Document Type: Article

References (25)

1. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe preeclamptic pregnancies. Br J Obstet Gynecol 1994; 101: 669-74.
2. Madazlý R, Budak E, Calay Z, Aksu MF. Correlation between placental bed biopsy findings, vascular cell adhesion molecule (VCAM-1) and fibronectin levels in preeclampsia. Br J Obstet Gynecol 2000; 107: 514-8.
3. Lala PK, Hamilton GS. Growth factors, proteases and protease inhibitors in the maternal-fetal dialogue. Placenta 1996; 17: 545-55.
4. Graham CH, Lala PK. Mechanism of control of placental invasion of the uterus and their control. Biochem Cell Biol 1992; 70: 867-74.
5. Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997; 37: 240-9.
6. Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry TS. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997; 18: 657-65.
7. Ferrera N, Hounck K, Jakeman L, Leung DW. Molecular and biological properties of vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13: 18-32.
8. Livingston JC, Chin R, Haddad B, McKinney ET, Ahokas R, Sibai BM. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol 2000; 183: 1554-7.
9. Reuvekamp A, Velsing-Aarts FV, Poulina IEJ, Capello JJ, Duits AJ. Selective deficit of angiogenic growth factors characterises pregnancies complicated by preeclampsia. Br J Obstet Gynecol 1999; 106: 1019-22.
10. Baker PN, Krasnow J, Roberts JM, Yeo KT. Elevated plasma concentrations of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 1995; 86: 815-21.
11. Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M, Lye SJ. Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 1999; 103: 1641-50.
12. Djurovic S, Schjetlein R, Wisloff F, Haugen G, Husby H, Berg K. Plasma concentrations of Lp (a) lipoprotein and TGF-beta 1 is altered in preeclampsia. Clin Genet 1997; 52: 371-6.
13. Shaarawy M, El Meleigy M, Rasheed K. Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of the severity and fetal outcome. J Soc Gynecol Invest 2001; 8: 27-31.
14. Pijnenborg R, McLaughlin PJ, Vercruysse L, Hanssens M, Johnson PM. Immunolocalization of tumour necrosis factor-α in the placental bed of normotensive and hypertensive human pregnancies. Placenta 1998; 19: 231-9.
15. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WHH, Martin JN, Bennett WA. Expression of the placental cytokines tumor necrosis factor α, interleukin 1 beta and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 1999; 181: 915-20.
16. Williams MA, Farrand A, Mittendorf R, Sorensen TK, Zingheim RW, O'Reilly GC et al. Maternal second trimester serum tumor necrosis factor α - soluble receptor p55 and subsequent risk of preeclampsia. Am J Epidemiol 1999; 149: 323-9.
17. Vuoral P, Hatva E, Lymboussaki A, Kaipainen A, Joukov V, Persico MG et al. Expression of vascular endothelial growth factor and placental growth factor in human placenta. Biol Reprod 1997; 56: 489-94.
18. Lyall F, Young A, Boswell F, Kingdom JCP, Greer IA. Placental expression of vascular endothelial growth factor in placenta from pregnancies complicated by preeclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 1997; 18: 269-76.
19. Cooper JC, Sharkey AM, Charnock-Jones DS, Palmer CR, Smith SK. VEGF mRNA levels in placenta from pregnancies complicated by preeclampsia. Br J Obstet Gynecol 1996; 103: 1191-6.
20. Hsuan JJ. Transforming growth factors beta. Br Med Bull 1989; 45: 425-37.
21. Dungy LJ, Siddigi TA, Khan S. Transforming growth factor- beta 1 expression during placental development. Am J Obstet Gynecol 1991; 165: 853-7.
22. Výnce GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CWG. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with preeclampsia. Br J Obstet Gynecol 1995; 102: 20-5.
23. Eneroth E, Remberger M, Vahlne A, Ringden O. Increased serum concentrations of interleukin-2 receptor in the first trimester in women who later developed severe preeclampsia. Acta Obstet Gynecol 1998; 77: 591-3.
24. Dekker GA, Sibai BM. The immunology of preeclampsia. Seminars Perinat 1999; 23: 24-33.
25. Wegman TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14: 353-7.